DLD Asset Management’s Audentes Therapeutics BOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-60,000
Closed -$3.59M – 126
2019
Q4
$3.59M Buy
+60,000
New +$2.25M 0.19% 42

DLD Asset Management's BOLD Position: Q1 2020 in Review

DLD Asset Management sold out of Audentes Therapeutics (BOLD) in Q1 2020, closing a stake of 60,000 shares — an estimated $3.59M sold.

DLD Asset Management first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $3.59M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • DLD Asset Management reported no remaining Audentes Therapeutics position as of Q1 2020 after selling out during the quarter.
  • DLD Asset Management sold 60,000 Audentes Therapeutics shares in Q1 2020, an estimated $3.59M.
  • DLD Asset Management first reported a position in Audentes Therapeutics in Q4 2019 and held it in 1 quarter.
  • DLD Asset Management's Audentes Therapeutics position peaked at $3.59M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics as of Q1 2020.

Based on DLD Asset Management's 13F filing for Q1 2020, filed 14 May 2020.